27 Jan 2022
GESlabs licenced by SAHPRA to produce cannabinoid pharma ingredients
By Staff Writer
After two years of design, build, inspection and collaboration, the South African Health Products Regulatory Authority (SAHPRA) has licenced GESLabs to manufacture cannabinoid active pharmaceutical ingredients (APIs) at its new South African production laboratory. GESLabs has attracted R20m of foreign direct investment and has established a world-class pharmaceutical laboratory in Cape Town, South Africa, which...
